En Carta Diagnostics vs Mironid
En Carta Diagnostics vs Mironid, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: En Carta Diagnostics is on 52/100 and Mironid on 59/100.
Where each one leads
En Carta Diagnostics
- LinkedIn following: 2,091 against 1,388
Mironid
- our overall score: 59/100 against 52/100
- domain rating: 13/100 against 0/100
- headcount: 16 against 12
- funding raised: $46.0M against $5.0M
At a glance
| Measure | En Carta Diagnostics | Mironid |
|---|---|---|
| What it is | Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity. | Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD). |
| Category | Biotechnology, HealthTech, Diagnostics, Medical Devices | Biotechnology, Pharmaceuticals, Drug Discovery, Medical Devices |
| Sells toBusiness model | B2B2C | B2B |
| Offering | Hardware | Platform |
| Founded | 2022 | 2015 |
| Headquarters | Paris, France | Glasgow, United Kingdom |
| Status | Inactive | Active |
Size, funding and growth
| Measure | En Carta Diagnostics | Mironid |
|---|---|---|
| Employees | 12 | 16 |
| Total funding | $5.0M | $46.0M |
| Latest round | Seed | Series B |
| LinkedIn followers | 2,091 | 1,388 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | En Carta Diagnostics | Mironid |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 52/100 | 59/100 |
| Traction | 45/100 | 51/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 20/100 | 20/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (21/100) |
| Domain ratingLink authority, 0-100 | 0/100 | 13/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | En Carta Diagnostics | Mironid |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery, Tailwind CSS, Bootstrap |
En Carta Diagnostics vs Mironid: common questions
Which is better, En Carta Diagnostics or Mironid?
On our 0-100 score Mironid rates higher (59/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do En Carta Diagnostics and Mironid compare on the numbers?
En Carta Diagnostics leads on LinkedIn following (2,091 against 1,388). Mironid leads on our overall score (59/100 against 52/100), domain rating (13/100 against 0/100), headcount (16 against 12), funding raised ($46.0M against $5.0M).
Read the full En Carta Diagnostics review and pricing or the Mironid review and pricing. You can also browse other En Carta Diagnostics alternatives we track.